{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:59:58Z","timestamp":1793105998249,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T00:00:00Z","timestamp":1516924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T00:00:00Z","timestamp":1516924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>N6-methyladenosine (m6A) is the most abundant mRNA modification. With the development of antibody-based sequencing technologies and the findings of m6A-related \u201cwriters\u201d, \u201cerasers\u201d, and \u201creaders\u201d, the relationships between m6A and mRNA metabolism are emerging. The m6A modification influences almost every step of RNA metabolism that comprises mRNA processing, mRNA exporting from nucleus to cytoplasm, mRNA translation, mRNA decay, and the biogenesis of long-non-coding RNA (lncRNA) and microRNA (miRNA). Recently, more and more studies have found m6A is associated with cancer, contributing to the self-renewal of cancer stem cell, promotion of cancer cell proliferation, and resistance to radiotherapy or chemotherapy. Inhibitors of m6A-related factors have been explored, and some of them were identified to inhibit cancer progression, indicating that m6A could be a target for cancer therapy. In this review, we are trying to summarize the regulation and function of m6A in human carcinogenesis.<\/jats:p>","DOI":"10.1038\/s41419-017-0129-x","type":"journal-article","created":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T12:00:57Z","timestamp":1516968057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":365,"title":["N6-methyladenosine links RNA metabolism to cancer progression"],"prefix":"10.1038","volume":"9","author":[{"given":"Dongjun","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,26]]},"reference":[{"key":"129_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrg3724","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu, Y., Dominissini, D., Rechavi, G. & He, C. Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat. Rev. Genet. 15, 293\u2013306 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"129_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0092-8674(75)90158-0","volume":"4","author":"CM Wei","year":"1975","unstructured":"Wei, C. M., Gershowitz, A. & Moss, B. Methylated nucleotides block 5\u2019 terminus of HeLa cell messenger RNA. Cell 4, 379\u2013386 (1975).","journal-title":"Cell"},{"key":"129_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0092-8674(74)90131-7","volume":"3","author":"F Rottman","year":"1974","unstructured":"Rottman, F., Shatkin, A. J. & Perry, R. P. Sequences containing methylated nucleotides at the 5\u2019 termini of messenger RNAs: possible implications for processing. Cell 3, 197\u2013199 (1974).","journal-title":"Cell"},{"key":"129_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nmeth.3453","volume":"12","author":"B Linder","year":"2015","unstructured":"Linder, B. et al Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat. Methods 12, 767\u2013772 (2015).","journal-title":"Nat. Methods"},{"key":"129_CR5","doi-asserted-by":"crossref","first-page":"20117","DOI":"10.1016\/S0021-9258(17)30477-5","volume":"265","author":"T Csepany","year":"1990","unstructured":"Csepany, T., Lin, A., Baldick, C. J. Jr. & Beemon, K. Sequence specificity of mRNA N6-adenosine methyltransferase. J. Biol. Chem. 265, 20117\u201320122 (1990).","journal-title":"J. Biol. Chem."},{"key":"129_CR6","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1021\/bi00627a023","volume":"16","author":"CM Wei","year":"1977","unstructured":"Wei, C. M. & Moss, B. Nucleotide sequences at the N6-methyladenosine sites of HeLa cell messenger ribonucleic acid. Biochemistry 16, 1672\u20131676 (1977).","journal-title":"Biochemistry"},{"key":"129_CR7","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1128\/MCB.10.9.4456","volume":"10","author":"SM Carroll","year":"1990","unstructured":"Carroll, S. M., Narayan, P. & Rottman, F. M. N6-methyladenosine residues in an intron-specific region of prolactin pre-mRNA. Mol. Cell. Biol. 10, 4456\u20134465 (1990).","journal-title":"Mol. Cell. Biol."},{"key":"129_CR8","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/jvi.42.3.918-931.1982","volume":"42","author":"CM Stoltzfus","year":"1982","unstructured":"Stoltzfus, C. M. & Dane, R. W. Accumulation of spliced avian retrovirus mRNA is inhibited in S-adenosylmethionine-depleted chicken embryo fibroblasts. J. Virol. 42, 918\u2013931 (1982).","journal-title":"J. Virol."},{"key":"129_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2017","unstructured":"Zhao, B. S., Roundtree, I. A. & He, C. Post-transcriptional gene regulation by mRNA modifications. Nat. Rev. Mol. Cell. Biol. 18, 31\u201342 (2017).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"129_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nrg3861","volume":"16","author":"S Kirchner","year":"2015","unstructured":"Kirchner, S. & Ignatova, Z. Emerging roles of tRNA in adaptive translation, signalling dynamics and disease. Nat. Rev. Genet. 16, 98\u2013112 (2015).","journal-title":"Nat. Rev. Genet."},{"key":"129_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nrc3195","volume":"12","author":"GT Williams","year":"2012","unstructured":"Williams, G. T. & Farzaneh, F. Are snoRNAs and snoRNA host genes new players in cancer? Nat. Rev. Cancer 12, 84\u201388 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"129_CR12","doi-asserted-by":"publisher","first-page":"e983755","DOI":"10.4161\/23723556.2014.983755","volume":"2","author":"V Marcel","year":"2015","unstructured":"Marcel, V., Catez, F. & Diaz, J. J. Ribosome heterogeneity in tumorigenesis: the rRNA point of view. Mol. Cell. Oncol. 2, e983755 (2015).","journal-title":"Mol. Cell. Oncol."},{"key":"129_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt, A. M. & Chang, H. Y. Long noncoding RNAs in cancer pathways. Cancer Cell 29, 452\u2013463 (2016).","journal-title":"Cancer Cell"},{"key":"129_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/138920210793175895","volume":"11","author":"LA Macfarlane","year":"2010","unstructured":"Macfarlane, L. A. & Murphy, P. R. MicroRNA: biogenesis, function and role in cancer. Curr. Genomics 11, 537\u2013561 (2010).","journal-title":"Curr. Genomics"},{"key":"129_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-1-r14","volume":"15","author":"B Kechavarzi","year":"2014","unstructured":"Kechavarzi, B. & Janga, S. C. Dissecting the expression landscape of RNA-binding proteins in human cancers. Genome Biol. 15, R14 (2014).","journal-title":"Genome Biol."},{"key":"129_CR16","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s11095-011-0604-5","volume":"28","author":"Z Wang","year":"2011","unstructured":"Wang, Z., Rao, D. D., Senzer, N. & Nemunaitis, J. RNA interference and cancer therapy. Pharm. Res. 28, 2983\u20132995 (2011).","journal-title":"Pharm. Res."},{"key":"129_CR17","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1074\/jbc.M116.749689","volume":"292","author":"Z Yang","year":"2017","unstructured":"Yang, Z. et al. MicroRNA-145 modulates N6-methyladenosine levels by targeting the 3\u2019-untranslated mRNA region of the N6-methyladenosine binding YTH domain family 2 protein. J. Biol. Chem. 292, 3614\u20133623 (2017).","journal-title":"J. Biol. Chem."},{"key":"129_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nature21671","volume":"543","author":"Y Xiang","year":"2017","unstructured":"Xiang, Y. et al. RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Nature 543, 573\u2013576 (2017).","journal-title":"Nature"},{"key":"129_CR19","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","volume":"18","author":"Q Cui","year":"2017","unstructured":"Cui, Q. et al. m6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells. Cell Rep. 18, 2622\u20132634 (2017).","journal-title":"Cell Rep."},{"key":"129_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase. Cancer Cell 31, 127\u2013141 (2017).","journal-title":"Cancer Cell"},{"key":"129_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/hep.28885","volume":"65","author":"JZ Ma","year":"2017","unstructured":"Ma, J. Z. et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6-methyladenosine-dependent primary microRNA processing. Hepatology 65, 529\u2013543 (2017).","journal-title":"Hepatology"},{"key":"129_CR22","doi-asserted-by":"crossref","first-page":"64527","DOI":"10.18632\/oncotarget.11743","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells. Oncotarget 7, 64527\u201364542 (2016).","journal-title":"Oncotarget"},{"key":"129_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin, S., Choe, J., Du, P., Triboulet, R. & Gregory, R. I. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol. Cell 62, 335\u2013345 (2016).","journal-title":"Mol. Cell"},{"key":"129_CR24","doi-asserted-by":"publisher","first-page":"E2047","DOI":"10.1073\/pnas.1602883113","volume":"113","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m(6)A-demethylation of NANOG mRNA. Proc. Natl Acad. Sci. USA 113, E2047\u2013E2056 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"129_CR25","first-page":"1233","volume":"3","author":"JA Bokar","year":"1997","unstructured":"Bokar, J. A., Shambaugh, M. E., Polayes, D., Matera, A. G. & Rottman, F. M. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA 3, 1233\u20131247 (1997).","journal-title":"RNA"},{"key":"129_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu, J. et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat. Chem. Biol. 10, 93\u201395 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"129_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang, P., Doxtader, K. A. & Nam, Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol. Cell 63, 306\u2013317 (2016).","journal-title":"Mol. Cell"},{"key":"129_CR28","doi-asserted-by":"publisher","first-page":"33292","DOI":"10.1074\/jbc.M113.500397","volume":"288","author":"K Horiuchi","year":"2013","unstructured":"Horiuchi, K. et al. Identification of Wilms\u2019 tumor 1-associating protein complex and its role in alternative splicing and the cell cycle. J. Biol. Chem. 288, 33292\u201333302 (2013).","journal-title":"J. Biol. Chem."},{"key":"129_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","volume":"8","author":"S Schwartz","year":"2014","unstructured":"Schwartz, S. et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5\u2019 sites. Cell Rep. 8, 284\u2013296 (2014).","journal-title":"Cell Rep."},{"key":"129_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil, D. P. et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537, 369\u2013373 (2016).","journal-title":"Nature"},{"key":"129_CR31","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","volume":"169","author":"KE Pendleton","year":"2017","unstructured":"Pendleton, K. E. et al The U6 snRNA m6A methyltransferase METTL16 regulates SAM synthetase intron retention. Cell 169, 824\u2013835 e814 (2017).","journal-title":"Cell"},{"key":"129_CR32","doi-asserted-by":"publisher","first-page":"20734","DOI":"10.1074\/jbc.R115.656462","volume":"290","author":"BI Fedeles","year":"2015","unstructured":"Fedeles, B. I., Singh, V., Delaney, J. C., Li, D. & Essigmann, J. M. The AlkB family of Fe(II)\/alpha-ketoglutarate-dependent dioxygenases: repairing nucleic acid alkylation damage and beyond. J. Biol. Chem. 290, 20734\u201320742 (2015).","journal-title":"J. Biol. Chem."},{"key":"129_CR33","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia, G. et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7, 885\u2013887 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"129_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng, G. et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol. Cell 49, 18\u201329 (2013).","journal-title":"Mol. Cell"},{"key":"129_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis, C. D. & Jenuwein, T. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487\u2013500 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"129_CR36","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","volume":"135","author":"T Geuens","year":"2016","unstructured":"Geuens, T., Bouhy, D. & Timmerman, V. The hnRNP family: insights into their role in health and disease. Hum. Genet. 135, 851\u2013867 (2016).","journal-title":"Hum. Genet."},{"key":"129_CR37","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature14234","volume":"518","author":"N Liu","year":"2015","unstructured":"Liu, N. et al N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature 518, 560\u2013564 (2015).","journal-title":"Nature"},{"key":"129_CR38","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","volume":"162","author":"CR Alarcon","year":"2015","unstructured":"Alarcon, C. R.et al. HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell 162, 1299\u20131308 (2015).","journal-title":"Cell"},{"key":"129_CR39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","volume":"163","author":"KD Meyer","year":"2015","unstructured":"Meyer, K. D. et al. 5\u2019 UTR m(6)A promotes cap-independent translation. Cell 163, 999\u20131010 (2015).","journal-title":"Cell"},{"key":"129_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0092-8674(76)90022-2","volume":"7","author":"M Salditt-Georgieff","year":"1976","unstructured":"Salditt-Georgieff, M. et al Methyl labeling of HeLa cell hnRNA: a comparison with mRNA. Cell 7, 227\u2013237 (1976).","journal-title":"Cell"},{"key":"129_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping, X. L. et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 24, 177\u2013189 (2014).","journal-title":"Cell Res."},{"key":"129_CR42","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","volume":"61","author":"W Xiao","year":"2016","unstructured":"Xiao, W. et al. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Mol. Cell 61, 507\u2013519 (2016).","journal-title":"Mol. Cell"},{"key":"129_CR43","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/cr.2014.151","volume":"24","author":"X Zhao","year":"2014","unstructured":"Zhao, X. et al. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 24, 1403\u20131419 (2014).","journal-title":"Cell Res."},{"key":"129_CR44","doi-asserted-by":"publisher","first-page":"a003707","DOI":"10.1101\/cshperspect.a003707","volume":"3","author":"CL Will","year":"2011","unstructured":"Will, C. L. & Luhrmann, R. Spliceosome structure and function. Cold Spring Harb. Perspect. Biol. 3, a003707 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"129_CR45","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cell.2013.10.026","volume":"155","author":"JM Fustin","year":"2013","unstructured":"Fustin, J. M. et al. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell 155, 793\u2013806 (2013).","journal-title":"Cell"},{"key":"129_CR46","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell 161, 1388\u20131399 (2015).","journal-title":"Cell"},{"key":"129_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/cr.2017.15","volume":"27","author":"H Shi","year":"2017","unstructured":"Shi, H. et al. YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. Cell Res. 27, 315\u2013328 (2017).","journal-title":"Cell Res."},{"key":"129_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12626","volume":"7","author":"H Du","year":"2016","unstructured":"Du, H. et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat. Commun. 7, 12626 (2016).","journal-title":"Nat. Commun."},{"key":"129_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505, 117\u2013120 (2014).","journal-title":"Nature"},{"key":"129_CR50","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.celrep.2016.07.006","volume":"16","author":"M Shah","year":"2016","unstructured":"Shah, M. et al. A transcript-specific eIF3 complex mediates global translational control of energy metabolism. Cell Rep. 16, 1891\u20131902 (2016).","journal-title":"Cell Rep."},{"key":"129_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini, D. et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201\u2013206 (2012).","journal-title":"Nature"},{"key":"129_CR52","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cell.2013.02.012","volume":"152","author":"PJ Batista","year":"2013","unstructured":"Batista, P. J. & Chang, H. Y. Long noncoding RNAs: cellular address codes in development and disease. Cell 152, 1298\u20131307 (2013).","journal-title":"Cell"},{"key":"129_CR53","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ncb3328","volume":"18","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat. Cell Biol. 18, 431\u2013442 (2016).","journal-title":"Nat. Cell Biol."},{"key":"129_CR54","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/abbs\/gmq008","volume":"42","author":"F Guo","year":"2010","unstructured":"Guo, F., Li, Y., Liu, Y., Wang, J. & Li, G. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim. Biophys. Sin. 42, 224\u2013229 (2010).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"129_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.stem.2015.01.016","volume":"16","author":"T Chen","year":"2015","unstructured":"Chen, T. et al. m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency. Cell Stem Cell 16, 289\u2013301 (2015).","journal-title":"Cell Stem Cell"},{"key":"129_CR56","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature14281","volume":"519","author":"CR Alarcon","year":"2015","unstructured":"Alarcon, C. R., Lee, H., Goodarzi, H., Halberg, N. & Tavazoie, S. F. N6-methyladenosine marks primary microRNAs for processing. Nature 519, 482\u2013485 (2015).","journal-title":"Nature"},{"key":"129_CR57","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.stem.2014.09.019","volume":"15","author":"PJ Batista","year":"2014","unstructured":"Batista, P. J. et al. m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell 15, 707\u2013719 (2014).","journal-title":"Cell Stem Cell"},{"key":"129_CR58","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.stem.2015.09.005","volume":"17","author":"F Aguilo","year":"2015","unstructured":"Aguilo, F. et al. Coordination of m(6)A mRNA methylation and gene transcription by ZFP217 regulates pluripotency and reprogramming. Cell Stem Cell 17, 689\u2013704 (2015).","journal-title":"Cell Stem Cell"},{"key":"129_CR59","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1101\/gad.1973010","volume":"24","author":"CJ David","year":"2010","unstructured":"David, C. J. & Manley, J. L. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 24, 2343\u20132364 (2010).","journal-title":"Genes Dev."},{"key":"129_CR60","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nsmb.1608","volume":"16","author":"JP Venables","year":"2009","unstructured":"Venables, J. P. et al. Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol. 16, 670\u2013676 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"129_CR61","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.neo.2016.09.002","volume":"18","author":"I Kotta-Loizou","year":"2016","unstructured":"Kotta-Loizou, I., Vasilopoulos, S. N., Coutts, R. H. & Theocharis, S. Current evidence and future perspectives on HuR and breast cancer development, prognosis, and treatment. Neoplasia 18, 674\u2013688 (2016).","journal-title":"Neoplasia"},{"key":"129_CR62","doi-asserted-by":"publisher","first-page":"10015","DOI":"10.3390\/ijms140510015","volume":"14","author":"J Wang","year":"2013","unstructured":"Wang, J. et al Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis. Int. J. Mol. Sci. 14, 10015\u201310041 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"129_CR63","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-4598-11-13","volume":"11","author":"E Latorre","year":"2012","unstructured":"Latorre, E. et al Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells. Mol. Cancer 11, 13 (2012).","journal-title":"Mol. Cancer"},{"key":"129_CR64","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/wrna.4","volume":"1","author":"K Abdelmohsen","year":"2010","unstructured":"Abdelmohsen, K. & Gorospe, M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip. Rev. RNA 1, 214\u2013229 (2010).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"129_CR65","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte, M. The emerging role of lncRNAs in cancer. Nat. Med. 21, 1253\u20131261 (2015).","journal-title":"Nat. Med."},{"key":"129_CR66","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes, J., Peruzzi, P. P. & Lawler, S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol. Med. 20, 460\u2013469 (2014).","journal-title":"Trends Mol. Med."},{"key":"129_CR67","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","volume":"14","author":"T Oskarsson","year":"2014","unstructured":"Oskarsson, T., Batlle, E. & Massague, J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell 14, 306\u2013321 (2014).","journal-title":"Cell Stem Cell"},{"key":"129_CR68","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","volume":"69","author":"E Charafe-Jauffret","year":"2009","unstructured":"Charafe-Jauffret, E. et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69, 1302\u20131313 (2009).","journal-title":"Cancer Res."},{"key":"129_CR69","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/ijc.28690","volume":"135","author":"LE Iv Santaliz-Ruiz","year":"2014","unstructured":"Iv Santaliz-Ruiz, L. E., Xie, X., Old, M., Teknos, T. N. & Pan, Q. Emerging role of nanog in tumorigenesis and cancer stem cells. Int. J. Cancer 135, 2741\u20132748 (2014).","journal-title":"Int. J. Cancer"},{"key":"129_CR70","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/onc.2011.338","volume":"31","author":"O Leis","year":"2012","unstructured":"Leis, O. et al. Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31, 1354\u20131365 (2012).","journal-title":"Oncogene"},{"key":"129_CR71","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1038\/onc.2010.591","volume":"30","author":"F Yu","year":"2011","unstructured":"Yu, F. et al. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 30, 2161\u20132172 (2011).","journal-title":"Oncogene"},{"key":"129_CR72","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.1158\/0008-5472.CAN-07-6642","volume":"68","author":"T Hu","year":"2008","unstructured":"Hu, T.et al. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res. 68, 6533\u20136540 (2008).","journal-title":"Cancer Res."},{"key":"129_CR73","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ng.127","volume":"40","author":"I Ben-Porath","year":"2008","unstructured":"Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499\u2013507 (2008).","journal-title":"Nat. Genet."},{"key":"129_CR74","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.bbrc.2016.11.077","volume":"482","author":"M Du","year":"2017","unstructured":"Du, M. et al. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA. Biochem. Biophys. Res. Commun. 482, 582\u2013589 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"129_CR75","first-page":"323","volume":"30","author":"JC Lu","year":"1989","unstructured":"Lu, J. C. & Lin, M. T. Paroxysmal nocturnal hemoglobinuria: report of one case. Zhonghua Min. Guo Xiao Er Ke Yi Xue Hui Za Zhi 30, 323\u2013325 (1989).","journal-title":"Zhonghua Min. Guo Xiao Er Ke Yi Xue Hui Za Zhi"},{"key":"129_CR76","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1182\/blood-2011-06-362079","volume":"119","author":"J Wang","year":"2012","unstructured":"Wang, J., Muntean, A. G. & Hess, J. L. ECSASB2 mediates MLL degradation during hematopoietic differentiation. Blood 119, 1151\u20131161 (2012).","journal-title":"Blood"},{"key":"129_CR77","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1074\/jbc.M108476200","volume":"277","author":"FC Guibal","year":"2002","unstructured":"Guibal, F. C. et al. ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells. J. Biol. Chem. 277, 218\u2013224 (2002).","journal-title":"J. Biol. Chem."},{"key":"129_CR78","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11060-011-0749-4","volume":"107","author":"DR Johnson","year":"2012","unstructured":"Johnson, D. R. & O\u2019Neill, B. P. Glioblastoma survival in the United States before and during the temozolomide era. J. Neurooncol. 107, 359\u2013364 (2012).","journal-title":"J. Neurooncol."},{"key":"129_CR79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4137\/CMO.S30271","volume":"9","author":"R Kalkan","year":"2015","unstructured":"Kalkan, R. Glioblastoma stem cells as a new therapeutic target for glioblastoma. Clin. Med. Insights Oncol. 9, 95\u2013103 (2015).","journal-title":"Clin. Med. Insights Oncol."},{"key":"129_CR80","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/07357907.2015.1025407","volume":"33","author":"M Ozen","year":"2015","unstructured":"Ozen, M. et al. Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression. Cancer Invest. 33, 251\u2013258 (2015).","journal-title":"Cancer Invest."},{"key":"129_CR81","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4149\/neo_2015_046","volume":"62","author":"Y Qi","year":"2015","unstructured":"Qi, Y., Li, X. & Zhao, S. miR-29b inhibits the progression of esophageal squamous cell carcinoma by targeting MMP-2. Neoplasma 62, 384\u2013390 (2015).","journal-title":"Neoplasma"},{"key":"129_CR82","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00432-013-1577-z","volume":"140","author":"R Lu","year":"2014","unstructured":"Lu, R. et al. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma. J. Cancer Res. Clin. Oncol. 140, 387\u2013397 (2014).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"129_CR83","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1440-1746.2012.07271.x","volume":"28","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y.et al. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma. J. Gastroenterol. Hepatol. 28, 565\u2013575 (2013).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"129_CR84","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","volume":"60","author":"MJ O\u2019Connor","year":"2015","unstructured":"O\u2019Connor, M. J. Targeting the DNA damage response in cancer. Mol. Cell 60, 547\u2013560 (2015).","journal-title":"Mol. Cell"},{"key":"129_CR85","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807\u20131812 (2008).","journal-title":"Science"},{"key":"129_CR86","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/2159-8290.CD-13-0083","volume":"3","author":"RA Cairns","year":"2013","unstructured":"Cairns, R. A. & Mak, T. W. Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. Cancer Discov. 3, 730\u2013741 (2013).","journal-title":"Cancer Discov."},{"key":"129_CR87","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ccell.2017.04.001","volume":"31","author":"SM Elkashef","year":"2017","unstructured":"Elkashef, S. M. et al. IDH mutation, competitive inhibition of FTO, and RNA methylation. Cancer Cell 31, 619\u2013620 (2017).","journal-title":"Cancer Cell"},{"key":"129_CR88","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10545-007-0487-0","volume":"30","author":"R Rzem","year":"2007","unstructured":"Rzem, R., Vincent, M. F., Van Schaftingen, E. & Veiga-da-Cunha, M. L-2-hydroxyglutaric aciduria, a defect of metabolite repair. J. Inherit. Metab. Dis. 30, 681\u2013689 (2007).","journal-title":"J. Inherit. Metab. Dis."},{"key":"129_CR89","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s10545-005-0114-x","volume":"28","author":"EA Struys","year":"2005","unstructured":"Struys, E. A.et al. Kinetic characterization of human hydroxyacid-oxoacid transhydrogenase: relevance to D-2-hydroxyglutaric and gamma-hydroxybutyric acidurias. J. Inherit. Metab. Dis. 28, 921\u2013930 (2005).","journal-title":"J. Inherit. Metab. Dis."},{"key":"129_CR90","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/hmg\/ddh300","volume":"13","author":"M Topcu","year":"2004","unstructured":"Topcu, M. et al. L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum. Mol. Genet. 13, 2803\u20132811 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"129_CR91","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1042\/BJ20031933","volume":"381","author":"Y Achouri","year":"2004","unstructured":"Achouri, Y. et al Identification of a dehydrogenase acting on D-2-hydroxyglutarate. Biochem. J. 381, 35\u201342 (2004).","journal-title":"Biochem. J."},{"key":"129_CR92","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","volume":"36","author":"J Zhang","year":"2017","unstructured":"Zhang, J., Pavlova, N. N. & Thompson, C. B. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 36, 1302\u20131315 (2017).","journal-title":"EMBO J."},{"key":"129_CR93","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00726-016-2254-8","volume":"48","author":"D Xiao","year":"2016","unstructured":"Xiao, D.et al. The glutamine-alpha-ketoglutarate (AKG) metabolism and its nutritional implications. Amino Acids 48, 2067\u20132080 (2016).","journal-title":"Amino Acids"},{"key":"129_CR94","doi-asserted-by":"publisher","first-page":"19885","DOI":"10.1074\/jbc.M211554200","volume":"278","author":"ML Martinez-Chantar","year":"2003","unstructured":"Martinez-Chantar, M. L. et al. L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of S-adenosylmethionine. J. Biol. Chem. 278, 19885\u201319890 (2003).","journal-title":"J. Biol. Chem."},{"key":"129_CR95","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/nature08921","volume":"464","author":"Z Han","year":"2010","unstructured":"Han, Z. et al. Crystal structure of the FTO protein reveals basis for its substrate specificity. Nature 464, 1205\u20131209 (2010).","journal-title":"Nature"},{"key":"129_CR96","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1093\/nar\/gku085","volume":"42","author":"W Aik","year":"2014","unstructured":"Aik, W. et al. Structure of human RNA N(6)-methyladenine demethylase ALKBH5 provides insights into its mechanisms of nucleic acid recognition and demethylation. Nucleic Acids Res. 42, 4741\u20134754 (2014).","journal-title":"Nucleic Acids Res."},{"key":"129_CR97","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nature11262","volume":"488","author":"L Kruidenier","year":"2012","unstructured":"Kruidenier, L. et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488, 404\u2013408 (2012).","journal-title":"Nature"},{"key":"129_CR98","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/anie.201107833","volume":"51","author":"EC Woon","year":"2012","unstructured":"Woon, E. C. et al. Linking of 2-oxoglutarate and substrate binding sites enables potent and highly selective inhibition of JmjC histone demethylases. Angew. Chem. Int. Ed. Engl. 51, 1631\u20131634 (2012).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"129_CR99","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1021\/ja201597b","volume":"133","author":"X Luo","year":"2011","unstructured":"Luo, X. et al. A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases. J. Am. Chem. Soc. 133, 9451\u20139456 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"129_CR100","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1021\/jm201417e","volume":"55","author":"EC Woon","year":"2012","unstructured":"Woon, E. C. et al. Dynamic combinatorial mass spectrometry leads to inhibitors of a 2-oxoglutarate-dependent nucleic acid demethylase. J. Med. Chem. 55, 2173\u20132184 (2012).","journal-title":"J. Med. Chem."},{"key":"129_CR101","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1021\/ja3064149","volume":"134","author":"B Chen","year":"2012","unstructured":"Chen, B. et al. Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J. Am. Chem. Soc. 134, 17963\u201317971 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"129_CR102","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/nar\/gku1276","volume":"43","author":"Y Huang","year":"2015","unstructured":"Huang, Y. et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res. 43, 373\u2013384 (2015).","journal-title":"Nucleic Acids Res."},{"key":"129_CR103","doi-asserted-by":"publisher","first-page":"e0121829","DOI":"10.1371\/journal.pone.0121829","volume":"10","author":"F McMurray","year":"2015","unstructured":"McMurray, F. et al. Pharmacological inhibition of FTO. PLoS ONE 10, e0121829 (2015).","journal-title":"PLoS ONE"},{"key":"129_CR104","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1021\/jm400193d","volume":"56","author":"W Aik","year":"2013","unstructured":"Aik, W. et al. Structural basis for inhibition of the fat mass and obesity associated protein (FTO). J. Med. Chem. 56, 3680\u20133688 (2013).","journal-title":"J. Med. Chem."},{"key":"129_CR105","doi-asserted-by":"publisher","first-page":"17299","DOI":"10.1074\/jbc.M114.550350","volume":"289","author":"C Xu","year":"2014","unstructured":"Xu, C. et al. Structures of human ALKBH5 demethylase reveal a unique binding mode for specific single-stranded N6-methyladenosine RNA demethylation. J. Biol. Chem. 289, 17299\u201317311 (2014).","journal-title":"J. Biol. Chem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0129-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0129-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0129-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:38:13Z","timestamp":1671536293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0129-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,26]]},"references-count":105,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["129"],"URL":"https:\/\/doi.org\/10.1038\/s41419-017-0129-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,26]]},"assertion":[{"value":"2 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"124"}}